Comments
Loading...
SELLAS Life Sciences Gr Earnings Estimates, EPS & Revenue | NASDAQ:SLS | Benzinga
SELLAS Life Sciences Gr reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 13
EPS
$-0.070
Quarterly Revenue
$0.00
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of SELLAS Life Sciences Gr using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SLS | SELLAS Life Sciences Gr | -$0.13 | — | — | — | $0.00 | — | — | — | 08/12/2025 | Get Alert |
| SLS | SELLAS Life Sciences Gr | -$0.21 | -$0.11 | -$0.07 | 36.36% | $0.00 | — | $0.00 | — | 05/13/2025 | Get Alert |
| SLS | SELLAS Life Sciences Gr | -$0.25 | -$0.11 | -$0.08 | 27.27% | $0.00 | — | $0.00 | — | 03/20/2025 | Get Alert |
| SLS | SELLAS Life Sciences Gr | -$0.33 | -$0.13 | -$0.10 | 23.08% | $0.00 | — | $0.00 | — | 11/13/2024 | Get Alert |
| SLS | SELLAS Life Sciences Gr | -$0.31 | -$0.17 | -$0.13 | 23.53% | $0.00 | — | $0.00 | — | 08/13/2024 | Get Alert |
| SLS | SELLAS Life Sciences Gr | -$0.47 | -$0.16 | -$0.21 | -31.25% | $0.00 | — | $0.00 | — | 05/14/2024 | Get Alert |
| SLS | SELLAS Life Sciences Gr | -$0.43 | -$0.21 | -$0.25 | -19.05% | $0.00 | — | $0.00 | — | 03/28/2024 | Get Alert |
| SLS | SELLAS Life Sciences Gr | -$0.34 | — | -$0.33 | — | $0.00 | $8.67M | $0.00 | -100.00% | 11/09/2023 | Get Alert |
| SLS | SELLAS Life Sciences Gr | -$0.41 | -$0.35 | -$0.31 | 11.43% | $0.00 | $3.25M | $0.00 | -100.00% | 08/10/2023 | Get Alert |
| SLS | SELLAS Life Sciences Gr | -$1.05 | -$0.29 | -$0.47 | -62.07% | $1.00M | — | $0.00 | — | 05/11/2023 | Get Alert |
| SLS | SELLAS Life Sciences Gr | -$0.42 | -$0.32 | -$0.43 | -34.38% | $0.00 | — | $0.00 | — | 03/16/2023 | Get Alert |
| SLS | SELLAS Life Sciences Gr | -$0.45 | -$0.39 | -$0.34 | 12.82% | $0.00 | — | $0.00 | — | 11/14/2022 | Get Alert |
| SLS | SELLAS Life Sciences Gr | -$0.30 | -$0.35 | -$0.41 | -17.14% | $1.90M | — | $0.00 | — | 08/11/2022 | Get Alert |
| SLS | SELLAS Life Sciences Gr | -$0.16 | — | -$1.05 | — | $5.70M | — | $1.00M | — | 05/12/2022 | Get Alert |
| SLS | SELLAS Life Sciences Gr | -$0.28 | -$0.41 | -$0.42 | -2.44% | $0.00 | — | $0.00 | — | 03/31/2022 | Get Alert |
| SLS | SELLAS Life Sciences Gr | -$0.53 | -$0.38 | -$0.45 | -18.42% | $0.00 | — | $0.00 | — | 11/12/2021 | Get Alert |
| SLS | SELLAS Life Sciences Gr | -$0.66 | -$0.32 | -$0.30 | 6.25% | $0.00 | — | $1.90M | — | 08/12/2021 | Get Alert |
| SLS | SELLAS Life Sciences Gr | -$0.66 | -$0.27 | -$0.16 | 40.74% | $0.00 | — | $5.70M | — | 05/13/2021 | Get Alert |
| SLS | SELLAS Life Sciences Gr | -$2.90 | — | -$0.28 | — | $0.00 | — | $0.00 | — | 03/21/2021 | Get Alert |
| SLS | SELLAS Life Sciences Gr | -$2.68 | — | -$0.53 | — | $0.00 | — | $0.00 | — | 11/13/2020 | Get Alert |
| SLS | SELLAS Life Sciences Gr | -$6.50 | — | -$0.66 | — | $0.00 | — | $0.00 | — | 08/13/2020 | Get Alert |
SELLAS Life Sciences Gr (SLS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-13 | $-0.07 | $-0.11 | 36.4 % |
| Q4 | 2025-03-20 | $-0.08 | $-0.11 | 27.3 % |
| Q3 | 2024-11-13 | $-0.10 | $-0.13 | 23.1 % |
| Q2 | 2024-08-13 | $-0.13 | $-0.17 | 23.5 % |
SELLAS Life Sciences Gr (SLS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2023-11-09 | $0 | $8.67M | -100.0 % |
| Q2 | 2023-08-10 | $0 | $3.25M | -100.0 % |
FAQ
When is SELLAS Life Sciences Gr (NASDAQ:SLS) reporting earnings?
SELLAS Life Sciences Gr (SLS) is scheduled to report earnings on August 12, 2025. The last reported earnings were for reported on May 13, 2025 for Q1.
What were the latest earnings per share (EPS) for SELLAS Life Sciences Gr (NASDAQ:SLS)?
The Actual EPS was $-0.07, which beat the estimate of $-0.11.
What were SELLAS Life Sciences Gr’s (NASDAQ:SLS) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.
